# Effectiveness and Safety of New Oral Antivirals for COVID-19

> **NCT05894603** · — · UNKNOWN · sponsor: **Universidade do Porto** · enrollment: 211 (actual)

## Conditions studied

- COVID-19

## Interventions

- **DRUG:** Nirmatrelvir/ritonavir
- **DRUG:** Molnupiravir

## Key facts

- **NCT ID:** NCT05894603
- **Lead sponsor:** Universidade do Porto
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-08-01
- **Primary completion:** 2024-01-31
- **Final completion:** 2024-06-30
- **Target enrollment:** 211 (ACTUAL)
- **Last updated:** 2023-12-18

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05894603

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05894603, "Effectiveness and Safety of New Oral Antivirals for COVID-19". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT05894603. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*